• TSX-V: NRM
  • OTCPINK: NRVTF
  • Frankfurt: N7R1

News Releases

Noram Completes CVZ-66: Ends In Mineralization At 462ft Continuing To Confirm Resource Dip And Direction

January 21, 2021

View News Release in German

Vancouver, British Columbia – January 21, 2021 – Noram Ventures Inc. (“Noram” or the “Company”) (TSX - Venture: NRM / Frankfurt: N7R / OTCQB: NRVTF) is pleased to announce the completion of its 6th hole of the Phase V 12-hole drill program. CVZ-66 was completed to a depth of 462ft and is one of the four deepest holes drilled to date showing mineralization below 400ft. An intersection of approximately 301 ft of favourable claystones was evident and drilling ended in blue claystone which has been shown in past programs to host significant amounts of lithium.


Figure 1a) Strip Log of CVZ-66 outlining the various claystone types encountered at depth from the surface to 462ft b) Zeus Property map showing a) location of current Indicated and Inferred resources at >900ppm Li cut-off; b) location of drill sites completed or in progress (seen in green) to date for the Phase V 2020 program. Proposed drill sites not yet explored indicated in white.

From (ft) To (ft) Lithology
0 122 Surface Gravel
122 161 Brown Sandy Mudstone
161 213 Olive Claystone/Mudstone
213 269 Blue Claystone/Mudstone
269 342 Blue-Black Claystone/Mudstone
342 462 Blue Claystone/Mudstone

Table 1 – Summary of Figure 1a Strip Log, describing the lithologies of CVZ-66 from surface to depth of 462ft.

“This is an important drill hole for Noram. The Company has not previously drilled in this area, nor at these depths; consequently, the results will significantly impact the resource modelling. From visual inspection alone, it appears that CVZ-66 once again confirms our theories on the uniform presence of the lakebed claystone deposits over a huge area or Noram’s claim block” commented Brad Peek, consulting geologist and Qualified Person for this and all 4 of the previous drilling phases of Noram’s Zeus lithium property.

Samples were sent to ALS Labs in North Vancouver on a rush basis and assays are pending. 

The technical information contained in this news release has been reviewed and approved by Brad Peek., M.Sc., CPG, who is a Qualified Person with respect to Noram’s Clayton Valley Lithium Project as defined under National Instrument 43-101.

About Noram Ventures Inc.

Noram Ventures Inc. (TSX - Venture: NRM / Frankfurt: N7R / OTCQB: NRVTF) is a Canadian based junior exploration company, with a goal of developing lithium deposits and becoming a low - cost supplier. The Company’s primary business is the Zeus Lithium Project (“Zeus”) in Clayton Valley, Nevada. The Zeus Project has a current resource estimate of 124 million tonnes at 1136 ppm lithium as Indicated Resources, and 77 million tonnes lithium at 1045 ppm lithium as Inferred Resources (900 ppm Li cut-off: 1.18 million tonnes lithium carbonate equivalent – “LCE”.

Noram’s long term strategy is to build a multi-national lithium minerals company to produce and sell lithium into the markets of Europe, North America and Asia.

Please visit our web site for further information: www.noramventures.com

ON BEHALF OF THE BOARD OF DIRECTORS
/s/ “Anita Algie”
Director and CFO
Office: (604) 553-2279

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking information which is not comprised of historical facts. Forward-looking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward-looking information in this news release includes statements regarding, among other things, the completion transactions completed in the Agreement. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, regulatory approval processes. Although Noram believes that the assumptions used in preparing the forward-looking information in this news release are reasonable, including that all necessary regulatory approvals will be obtained in a timely manner, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Noram disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by applicable securities laws.